Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma

Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature

(2013) B. Kiesewetter et al.   BLOOD

Exposure to animals and increased risk of marginal zone B-cell lymphomas of the ocular adnexae

(2012) R Dolcetti et al.   BRITISH JOURNAL OF CANCER

Chlamydophila PsittaciEradication With Doxycycline As First-Line Targeted Therapy for Ocular Adnexae Lymphoma: Final Results of an International Phase II Trial

(2012) Andrés J.M. Ferreri et al.   JOURNAL OF CLINICAL ONCOLOGY

Chlamydia psittaci in ocular adnexa MALT lymphoma: a possible role in lymphomagenesis and a different geographical distribution

(2012) Francesca Collina et al.   Infectious Agents and Cancer

Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)

(2010) Sung-Eun Lee et al.   AMERICAN JOURNAL OF HEMATOLOGY

First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective analysis of clinical predictors

(2010) Tae Min Kim et al.   CANCER SCIENCE

Extranodal marginal zone lymphoma of the ocular adnexa

(2009) A. Stefanovic et al.   BLOOD

Radiation therapy in primary orbital lymphoma: a single institution retrospective analysis

(2009) Luigi De Cicco et al.   Radiation Oncology

Chlamydia Infection and Lymphomas: Association Beyond Ocular Adnexal Lymphomas Highlighted by Multiple Detection Methods

(2008) M. Ponzoni et al.   CLINICAL CANCER RESEARCH

Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma

(2007) E.-K. Song et al.   ANNALS OF ONCOLOGY